Flagship Harbor Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Flagship Harbor Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Sell	29,492 -317	-1%	-$18.2K	0.07%	256
2026 Q1	$1.81M	Sell	29,809 -1,244	-4%	-$72.5K	0.08%	215
2025 Q4	$1.68M	Buy	31,053 +2,742	+10%	+$132K	0.08%	222
2025 Q3	$1.28M	Sell	28,311 -3,054	-10%	-$143K	0.06%	262
2025 Q2	$1.45M	Buy	31,365 +214	+0.7%	+$10.5K	0.07%	246
2025 Q1	$1.9M	Sell	31,151 -434	-1%	-$25.3K	0.1%	186
2024 Q4	$1.79M	Sell	31,585 -3,876	-11%	-$217K	0.09%	195
2024 Q3	$1.83M	Sell	35,461 -5,748	-14%	-$270K	0.1%	192
2024 Q2	$1.71M	Buy	41,209 +7,052	+21%	+$316K	0.1%	191
2024 Q1	$1.85M	Buy	34,157 +4,680	+16%	+$238K	0.12%	168
2023 Q4	$1.51M	Buy	29,477 +608	+2%	+$31.9K	0.11%	178
2023 Q3	$1.68M	Sell	28,869 -1,551	-5%	-$95K	0.14%	146
2023 Q2	$1.95M	Sell	30,420 -2,018	-6%	-$135K	0.16%	137
2023 Q1	$2.25M	Buy	32,438 +93	+0.3%	+$6.56K	0.21%	122
2022 Q4	$2.33M	Buy	32,345 +335	+1%	+$25.3K	0.24%	116
2022 Q3	$2.28M	Buy	32,010 +1,617	+5%	+$117K	0.26%	98
2022 Q2	$2.34M	Buy	30,393 +831	+3%	+$63.3K	0.26%	98
2022 Q1	$2.16M	Buy	29,562 +1,496	+5%	+$100K	0.21%	126
2021 Q4	$1.75M	Buy	28,066 +4,802	+21%	+$282K	0.17%	146
2021 Q3	$1.55M	Hold	23,264	–	–	0.17%	146
2021 Q2	$1.55M	Buy	23,264 +713	+3%	+$46.5K	0.17%	146
2021 Q1	$1.42M	Sell	22,551 -1,147	-5%	-$71.4K	0.16%	144
2020 Q4	$1.47M	Buy	23,698 +2,465	+12%	+$152K	0.18%	121
2020 Q3	$1.28M	Buy	21,233 +168	+0.8%	+$10.1K	0.17%	115
2020 Q2	$1.24M	Buy	21,065 +2,319	+12%	+$139K	0.18%	121
2020 Q1	$1.04M	Sell	18,746 -959	-5%	-$58.6K	0.21%	104
2019 Q4	$1.26M	Buy	19,705 +2,850	+17%	+$163K	0.22%	104
2019 Q3	$854K	Sell	16,855 -7,293	-30%	-$343K	0.17%	136
2019 Q2	$1.09M	Buy	24,148 +11,849	+96%	+$552K	0.23%	100
2019 Q1	$586K	Buy	12,299 +1,478	+14%	+$73.6K	0.12%	186
2018 Q4	$562K	Sell	10,821 -936	-8%	-$50.3K	0.14%	162
2018 Q3	$730K	Buy	11,757 +221	+2%	+$13.1K	0.14%	168
2018 Q2	$638K	Buy	11,536 +185	+2%	+$9.99K	0.13%	173
2018 Q1	$696K	Sell	11,351 -2,629	-19%	-$169K	0.21%	126
2017 Q4	$856K	Sell	13,980 -81	-0.6%	-$5.07K	0.25%	110
2017 Q3	$897K	Buy	14,061 +1,099	+8%	+$64.2K	0.29%	96
2017 Q2	$732K	Sell	12,962 -408	-3%	-$22.2K	0.25%	109
2017 Q1	$707K	Buy	13,370 +3,633	+37%	+$199K	0.27%	112
2016 Q4	$476K	Buy	+9,737	New	+$532K	0.21%	138

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Flagship Harbor Advisors's BMY Position: Q2 2026 in Review

Flagship Harbor Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, selling an estimated $18.2K and leaving 29,492 shares worth $1.7M. The position accounts for 0.07% of the portfolio, ranked #256.

Flagship Harbor Advisors first reported a position in BMY in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.34M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Flagship Harbor Advisors held 29,492 shares of Bristol-Myers Squibb worth $1.7M as of Q2 2026.
Flagship Harbor Advisors sold 317 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.2K.
Bristol-Myers Squibb made up 0.07% of Flagship Harbor Advisors's portfolio in Q2 2026, its #256 holding.
Flagship Harbor Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 39 quarters since.
Flagship Harbor Advisors's Bristol-Myers Squibb position peaked at $2.34M in Q2 2022.
879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.